Scientists have, for the first time, recreated an assembly of proteins known as the β-catenin destruction complex in the test tube. This is a long-awaited step in cancer research, as mutations in this destruction complex are found in a large percentage of bowel and other cancers.

A survey of more than 200 researchers details impact of the pandemic. The scientists estimate their own research has been put back by six months through loss of access to labs, facilities, trials and samples. But they feel science has now adapted to COVID-19 – and researchers believe donations and Government support could accelerate recovery.

Researchers have found drug fragments, which could help improve our understanding of the function of a key cancer protein and ultimately lead to new drug treatments.